Modified Response Evaluation Criteria in Solid Tumors (mRECIST)
Measures treatment response, specifically to cytotoxic drugs, based on tumor shrinkage.
INSTRUCTIONS
Use in liver lesions meeting the following criteria:
- Can be accurately measured in at least one dimension as 10 mm or more (measure longest diameter).
- Suitable for repeat measurement.
- Intratumoral arterial enhancement on contrast-enhanced CT or MRI.
Diagnostic Result
Please fill out required fields.
Dr. Josep Llovet
About the creator
Josep Llovet, MD, is a professor of medicine and founder and director of the Liver Cancer Program at Mount Sinai Hospital. He was the president, secretary and founder of the International Liver Cancer Association (ILCA) and Chairman of the European Clinical Practice Guidelines of management of liver cancer (EASL-EORTC). He is an active researcher investigating the pathogenesis and treatment of liver cancer.
To view Dr. Josep Llovet's publications, visit PubMed
Are you Dr. Josep Llovet? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.